In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
In this video, Ian Bouligny, MD, discusses his team’s research that aimed to determine the impact of secondary-type mutations in patients who were newly diagnosed with acute myeloid leukemia and treated...
